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Abstract: Most prior studies of primary diagnosis in surgical path-
ology using whole slide imaging (WSI) versus microscopy have
focused on speciﬁc organ systems or included relatively few cases.
The objective of this study was to demonstrate that WSI
is noninferior to microscopy for primary diagnosis in surgical path-
ology. A blinded randomized noninferiority study was conducted
across the entire range of surgical pathology cases (biopsies and re-
sections, including hematoxylin and eosin, immunohistochemistry,
and special stains) from 4 institutions using the original sign-out di-
agnosis (baseline diagnosis) as the reference standard. Cases were
scanned, converted to WSI and randomized. Sixteen pathologists
interpreted cases by microscopy or WSI, followed by a wash-out
period of ≥4 weeks, after which cases were read by the same ob-
servers using the other modality. Major discordances were identiﬁed
by an adjudication panel, and the differences between major dis-
cordance rates for both microscopy (against the reference standard)
and WSI (against the reference standard) were calculated. A total of
1992 cases were included, resulting in 15,925 reads. The major dis-
cordance rate with the reference standard diagnosis was 4.9% forWSI
and 4.6% for microscopy. The difference between major discordance
rates for microscopy and WSI was 0.4% (95% conﬁdence interval,
−0.30% to 1.01%). The difference in major discordance rates for WSI
and microscopy was highest in endocrine pathology (1.8%), neoplastic
kidney pathology (1.5%), urinary bladder pathology (1.3%), and gy-
necologic pathology (1.2%). Detailed analysis of these cases revealed
no instances where interpretation by WSI was consistently inaccurate
compared with microscopy for multiple observers. We conclude that
WSI is noninferior to microscopy for primary diagnosis in surgical
pathology, including biopsies and resections stained with hematoxylin
and eosin, immunohistochemistry and special stains. This conclusion
is valid across a wide variety of organ systems and specimen types.
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Whole slide imaging (WSI), also known as digitalpathology or virtual pathology, is a technology that
involves high-speed, high-resolution digital acquisition of
images representing entire stained tissue sections from
glass slides in a format that allows them to be viewed by a
pathologist on a computer monitor, where the image can
be magniﬁed and navigated spatially in much the same
way as standard microscopy.1 These images can be
utilized for diagnosis by pathologists, creating a digital
workﬂow that obviates the use of conventional bright
ﬁeld light microscopy (henceforth referred to as “micro-
scopy”). Before substituting the time-honored, familiar
and versatile microscope with WSI, several valid con-
cerns need to be addressed. The most critical one is
whether pathologic diagnoses rendered using WSI are
comparable with (ie, noninferior to) diagnoses made by
microscopy.2
Prior studies have compared WSI with microscopy
in several different settings in diagnostic pathology, in-
cluding frozen section diagnosis, consultation cases,3,4
difﬁcult surgical pathology cases,5 and pathology of spe-
ciﬁc organ systems or subspecialties.6–30 College of
American Pathologists (CAP) guidelines published in 2013
recommend that each intended use be supported by a
separate validation study.1 One intended use in surgical
pathology is primary diagnosis, deﬁned as establishing a
ﬁnal diagnosis solely by review of digital images without
the use of microscopy. Only a few validation studies have
addressed the use of WSI for primary diagnosis in surgical
pathology across a wide variety of specimen types from
different organ systems.31–42 Most of these have included
relatively small numbers of cases, and many were not
sufﬁciently powered to deﬁnitively demonstrate that WSI
is noninferior to microscopy for this purpose. In some
studies, issues with study design may have introduced the
possibility of bias. Factors creating a risk of bias include
patient selection, index test, reference standard, ﬂow and
timing, as recently described in detail by Goacher et al.43
A well-known example is the wash-out period; studies
with an inadequate wash-out period between microscopic
and WSI reads introduce the possibility of recall bias.
Studies that include readers in the adjudication process
may introduce an element of bias in determining whether
diagnoses made by microscopy and WSI are concordant.
With this background in mind, the primary objective of
our study was to demonstrate that WSI is noninferior to
microscopy for primary diagnosis across the entire range
of surgical pathology practice. Frozen section and cytol-
ogy cases were excluded. Hematopathology cases were
also omitted because of common use of higher magniﬁ-
cation objectives.
METHODS
Over a 14-month period (July 2015 to September
2016), a blinded randomized noninferiority study com-
paring microscopy with WSI for primary diagnosis in
surgical pathology was conducted at 4 institutions in the
United States (2 academic centers and 2 commercial
laboratories; the latter included an independent hospital-
based pathology practice). Investigators from pathology
departments at multiple other institutions were actively
involved in planning, study design, execution, and
data analysis. The study protocol was approved by
Institutional Review Boards (IRBs) at all participating
institutions.
Screening and Enrollment
Each participating institution was assigned a set of
organ systems from which to enroll cases, for a total of 20
organ systems (Table 1). Only formalin-ﬁxed parafﬁn-
embedded surgical pathology cases were enrolled. Frozen
sections and cases received in consultation were excluded.
Target enrollment for each organ system and case type
was predeﬁned, based on discussions with the United
States Food and Drug Administration (FDA), and were
intended to reﬂect routine clinical practice while enriching
for more difﬁcult malignant cases. As an example, for
colorectal cases, the enrollment target was 150 cases,
including 50 benign/inﬂammatory biopsies, 50 biopsies of
adenomas, 40 endoscopic biopsies of adenocarcinoma,
and 10 adenocarcinoma resections. Cases were excluded if
they met any of the following exclusion criteria: (1) slides
for a case were not available at the site, (2) control slides
for immunohistochemistry or special stains were not
available, (3) slides selected did not match any subtype
of the organ for which the case was selected, (4) clinical
information available to the sign-out pathologist in the
pathology requisition form could not be obtained, (5)
selected slides contained indelible markings, (6) more than
one case was selected for a patient, (7) the case consisted of
frozen section slides only, or (8) the case consisted of gross
specimens only. The most common reason for not
including a screened case was that the target enrollment
number for that speciﬁc diagnosis was met. For example,
once the target of 120 consecutive benign core biopsies of
prostate was reached, subsequent benign core biopsies
were not enrolled. By this process, 12,338 cases were
screened by 8 enrollment pathologists from 4 centers
until the enrollment target of 2000 cases (3405 slides) was
reached. These cases were submitted for scanning and
subsequent review.
The inclusion criteria speciﬁed that the interval
between accession of cases and selection into the study
was to be at least 1 year. Cases were reviewed for en-
rollment in the study by 2 “enrollment pathologists” per
institution. One of these individuals reviewed a list of
consecutive pathology reports from organ systems as-
signed to that center and ﬂagged cases for retrieval of
glass slides. All glass slides for each case were reviewed
(screened) by the enrollment pathologist. For biopsies,
the enrollment pathologist selected key slides required
for diagnosis, including hematoxylin and eosin and im-
munohistochemical stains. In addition, for resections,
representative slides required for diagnosis and staging
were selected, including negative or positive lymph nodes
and margins. The second enrollment pathologist (vali-
dating enrollment pathologist) then reviewed all slides
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selected by the ﬁrst enrollment pathologist to ensure that
diagnostic material reﬂecting the original diagnosis was
present. The original diagnosis made in the course of
routine patient care by the pathologist signing out the
case (baseline diagnosis) was considered the reference
standard.
TABLE 1. Cases Included in the Study (Full Analysis Set) by Organ System
Study Site Organ System No. Cases Organ (±Specimen Type)
1 Colorectal 150 Adenocarcinoma resection: 10
Benign/inﬂammatory biopsy: 50
Adenoma biopsy: 50
Adenocarcinoma endoscopic biopsy: 40
Urinary bladder 99 Carcinoma resection: 9
Benign/inﬂammatory/non-neoplastic biopsy: 25
Dysplasia biopsy: 25
Noninvasive carcinoma (TUR or biopsy): 25
Carcinoma (TUR or biopsy): 15
Gynecologic 150 Endometrial biopsy/curetting: 50
Cervical biopsy/curetting: 25
Cervical cone/LEEP: 25
Ovary benign neoplastic/non-neoplastic: 20
Ovary malignant neoplastic: 30
Liver/bile duct, neoplastic 49 Core biopsy: 39
Wedge biopsy or resection: 10
Brain 60 Non-neoplastic: 10
Neoplastic biopsy: 25
Neoplastic resection: 25
Total (site 1) 508
2 Prostate 299 Benign core biopsy: 120
Benign resection: 29
Adenocarcinoma biopsy: 120
Adenocarcinoma resection: 30
Lymph node 100 For presence/absence of metastasis: 75
Non-neoplastic: 25
Endocrine 100 Pancreas: 50
Thyroid: 30
Parathyroid: 10
Adrenal: 10
Kidney, neoplastic 50 Consecutive cases, all comers: 50
Salivary 50 Consecutive cases, all comers: 50
Total (site 2) 599
3 Gastroesophageal junction 115 Rule out Barrett/dysplasia: 50
Non-neoplastic/inﬂammatory biopsy: 65
Skin 177 Non-neoplastic/inﬂammatory biopsy: 50
Squamous/basal cell neoplasm, biopsy: 52
Melanocytic lesion, biopsy: 75
Hernial/peritoneal 7 Consecutive cases, all comers: 7
Gallbladder 10 Consecutive cases, all comers: 10
Appendix 10 Consecutive cases, all comers: 10
Soft tissue tumors 21 Consecutive cases, all comers: 21
Anus/perianal 50 Consecutive cases, all comers: 50
Total (site 3) 390
4 Breast 299 Benign/atypical core needle biopsy: 50
Benign/atypical lumpectomy: 50
In situ carcinoma core needle biopsy: 49
In situ carcinoma lumpectomy: 50
Invasive carcinoma core needle biopsy: 50
Invasive carcinoma lumpectomy: 50
Lung/bronchus/larynx/oral cavity/nasopharynx 95 Benign/inﬂammatory biopsy: 25
Dysplasia biopsy: 22
Carcinoma biopsy: 28
Carcinoma resection: 20
Stomach 99 Inﬂammatory including Helicobacter pylori: 50
Polyps/neoplastic biopsy: 39
Polyps/neoplastic resection: 10
Total (site 4) 495
Total for all 4 sites (full analysis set) 1992
TUR indicates transurethral resection.
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Slide Scanning
A study coordinator compiled all cases selected by
the enrollment pathologists and submitted them for digital
scanning at participating sites using the Philips IntelliSite
Pathology Solution (Philips, the Netherlands), which in-
cludes a scanner, an image management system and a
display. A study technician was trained to scan slides using
appropriate calibration and quality control measures. All
slides were scanned as WSI for digital review using the
Philips IntelliSite Pathology Solution.
Of the 2000 cases submitted for scanning, 8 (0.4%)
were excluded for the following reasons: slide size did not
meet scanner speciﬁcations (4 cases), no tissue was de-
tected by scanner on any one of the slides selected for the
case (2 cases), more than one case was selected for the
patient (1 case), or slides were broken or damaged (1 case).
This process yielded a “full analysis set” of 1992 cases
(99.6% of enrolled cases).
Randomization
Original glass slides from all cases included in the
study (full analysis set) were randomized and deidentiﬁed.
Randomization was performed within an Electronic Data
Capture (EDC) system provided by the manufacturer
(eCaseLink Document Solutions Group, Malvern, PA).
Original surgical pathology numbers were obscured and
replaced by a study identiﬁer (barcode label) by the study
coordinator. Cases were then placed in random order and
divided into batches of 20 cases, each of which contained a
random mix of cases from various organ systems.
Interpretation of Microscopy and Whole Slide
Images by Reading Pathologists
Randomized and deidentiﬁed slides from each case
were presented for interpretation to 16 board-certiﬁed
“reading pathologists” (4 at each center) different from the
8 enrollment pathologists whose role was described pre-
viously. Each reading pathologist followed standard
training including self-familiarization with the WSI view-
er. In order to represent the breadth of potential users of
WSI, reading pathologists were selected to represent a
variety of expertise, practice types (academic vs. non-
academic, generalists vs. subspecialists), subspecialty
training and years of experience. Reading pathologists
interpreted cases enrolled from their center only, blinded
to the reference standard diagnosis.
All cases were interpreted by 2 modalities. The ﬁrst
(microscopy) involved viewing glass slides using a micro-
scope, identical to the practice of routine surgical path-
ology. Each pathologist viewed glass slides in their ofﬁce
using their own microscope. The second method (WSI)
involved viewing scanned digital images on a high-reso-
lution monitor without the use of a microscope. Reading
pathologists interpreted cases in batches of 20. After a
batch of 20 cases was reviewed, the same pathologist was
given a separate batch of 20 cases for review by the other
modality. For example, a pathologist who interpreted
cases 1 to 20 using microscopy might be assigned cases 71
to 90 for review using WSI, followed by cases 41 to 60
using a microscope, and so on. This process was repeated
for all 16 reading pathologists until all assigned cases were
viewed by each pathologist. After a wash-out period of at
least 4 weeks, all cases were arranged in random order and
interpreted a second time by the same reading pathologists
using the other modality (ie, cases initially interpreted by
microscopy were interpreted by WSI and vice versa). The
wash-out period differed from case to case depending on
its order in the randomly arranged cases. The mean wash-
out period per pathologist ranged from 38.7 to 81.8 days.
The minimum wash-out period was 27 days and the
maximum was 143 days.
At least 2 workstations, each with a 27-inch monitor,
were provided to each participating site and located in a
room simulating a clinical practice environment. The di-
agnosis for each case was entered electronically into the
EDC electronic database by each reading pathologist.
Staging parameters on cases requiring staging were en-
tered on paper using templates that incorporated key el-
ements of CAP synoptic templates for each organ. The
time that a pathologist either opened or closed a case in
the EDC system was logged. Reading pathologists were
allowed to freely consult textbooks and other literature
online, whether using microscopy or WSI. Identical clin-
ical information was provided to reading pathologists for
both modalities. Information regarding prior diagnoses on
the same patient was not provided. Reading pathologists
were not allowed to request recuts or any additional spe-
cial stains beyond those already provided, or to consult
with other pathologists. The randomization process en-
sured that the order in which cases were presented to the
reading pathologist for microscopic interpretation was
different than the order for WSI interpretation.
Each diagnosis by a reading pathologist on a case
(whether by WSI or microscopy) was termed a “read.” As
each case from any participating institution was
interpreted twice by 4 reading pathologists, there were 8
“reads” per case, not including the original sign-out di-
agnosis.
Adjudication Phase
The diagnosis rendered by the original pathologist
who signed out the case in the course of routine patient
care using a microscope was considered the reference
standard. A central panel of 3 “adjudication pathologists”
independently determined the level of concordance be-
tween microscopic and WSI diagnoses and the reference
standard. The adjudication panel did not include any of
the enrollment pathologists or reading pathologists, and
was selected from institutions different than the 4 centers
that participated in enrollment and reading. Each ad-
judication pathologist had at least 10 years of relevant
experience.
Two adjudication pathologists were provided a list
of paired diagnoses, blinded to method of diagnosis (mi-
croscopy or WSI), reading pathologist and participating
site/institution. Adjudication pathologists did not view
glass slides for any case. Using an Adjudication Charter
for each organ system, adjudication pathologists placed
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each pair of diagnoses into one of 3 categories: con-
cordant, minor discordant or major discordant. In keeping
with widely accepted deﬁnitions, a major discordance was
deﬁned as a difference in diagnosis that would be asso-
ciated with a difference in patient management.32,44 In
case of a disagreement between the 2 adjudication path-
ologists on the level of concordance between 2 diagnoses,
the third adjudication pathologist served as a tie-breaker.
The primary endpoint of the study was the difference be-
tween major discordance rates for microscopy and WSI by
comparison with the reference standard. The study design
is summarized in Figure 1.
RESULTS
A total of 1992 cases (3390 slides/3390 images) were
included in the full analysis set, of which 923 slides (27%)
were either immunohistochemical stains or special stains.
The range of slides examined was 1 to 16 slides per case.
Ten cases had 10 or more slides per case. Scanning per-
formance is shown in Table 2. In the ﬁrst scan of these
3390 slides, the Philips IntelliSite Pathology Solution was
able to automatically detect an issue, such as no tissue or
label detection, for 77 slides (2.3%). The images from 70
slides (2.1%) did not pass the image quality check by the
scanning operator for slide-related issues such as prior ink
markings, broken slides or debris on the slide. For 55
images (1.6%) the scanning technician identiﬁed an out of
focus image (54 images, 1.6%) or missing tissue (1 image,
0.03%).
In the second scan (in cases where this was required),
the Philips IntelliSite Pathology Solution was able to au-
tomatically detect an issue for 21 slides (0.6%). The images
from 7 slides (0.2%) did not pass the image quality check
by the scanning operator for slide-related issues. For 22
images (0.6%), the scanning technician identiﬁed the im-
age to be out of focus for 21 images and found “venetian
blinds” at high magniﬁcation for 1 image. For clinical
study operational reasons, slides were rescanned a max-
imum of 5 times before they were enrolled into the study.
Reading times were derived from available system
data. Reading time was deﬁned as the time it took a
pathologist to open the case, read all available in-
formation, diagnose the case and enter the diagnosis in the
system. Approximately 94% of reads were completed
within 30 minutes of reading time. Reading times longer
than 30 minutes were considered to not reﬂect the actual
reading time since such instances generally occurred due to
external factors; for example, the reader opened the case,
was interrupted during the read, and forgot to close the
case, resulting in an incorrect log. For exploratory anal-
yses, and assuming that this would have the same effect on
microscopic reads as on WSI reads, it was decided to in-
clude only times shorter than 30 minutes for the analysis.
The mean reading time for microscopy was 78 seconds
and the mean reading time for WSI was 84 seconds. The
mean difference between the reading time for WSI and the
reading time for microscopy was 6 seconds with a 95%
conﬁdence interval (CI) of (0.03-0.12). One site in the
study performed a detailed analysis of reading times,
which is being published in a separate manuscript.45
The number of cases by organ system, diagnosis and
specimen type is shown in Table 1. For 1992 cases, a total
of 15,936 reads (1992×8) was expected. However, 11 reads
(7 by microscopy, 4 by WSI) were excluded as reading
FIGURE 1. Study design.
TABLE 2. Scanning Performance
Reasons for Not Passing
(% of Full Analysis Set)
Scanning
Attempt
Slides
Scanned
WSI
Passed
Detection by
PIPS
Slide-
related
Image-
related
1 3390 3179 2.3 2.1 1.6
2 202 152 0.6 0.2 0.6
PIPS indicates Philips IntelliSite Pathology Solution.
TABLE 3. Major Discordance Rates by Organ System:
Microscopy Versus Reference Standard and WSI Versus
Reference Standard
Major
Discordance
Rate
Between Microscopy and
Reference Standard (%)
Between WSI and
Reference Standard (%)
< 1% Peritoneal (0) Peritoneal (0)
Gallbladder (0) Gallbladder (0)
Appendix (0) Appendix (0)
Soft tissue (0) Soft tissue (0)
Stomach (0.5) Lymph node (0.3)
Lymph node (0.8) Stomach (0.8)
1%-4.9% Colorectal (1) Peri(anal) (1)
Kidney neoplastic (1) Colorectal (1.7)
Gastroesophageal
junction (1.3)
Salivary gland (2)
Peri(anal) (2) Gastroesophageal
junction (2)
Salivary gland (3) Kidney neoplastic (2.5)
Respiratory (4.2) Respiratory (3.5)
Breast (4.3) Breast (4.2)
Skin (4.7) Liver/bile duct (4.6)
Endocrine (4.7) Skin (4.9)
≥ 5% Gynecologic (5.2) Brain (6.2)
Liver/bile duct (5.6) Gynecologic (6.3)
Brain (5.8) Endocrine (6.5)
Bladder (6.1) Bladder (7.3)
Prostate (11.3) Prostate (12)
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pathologists selected “no diagnosis” for a variety of
reasons, yielding a total of 15,925 reads (7961 by
microscopy, 7964 by WSI).
The major discordance rate between microscopy and
the reference standard was 4.6% (364/7961 reads) and the
major discordance rate between WSI and the reference
standard was 4.9% (393/7964 reads). The difference in
major discordance rates for WSI and microscopy was
0.4%, with a derived 2-sided 95% CI of (−0.30% to
1.01%). As the upper limit of this CI was less than the
TABLE 4. Comparison of Major Discordance Rate for WSI and Major Discordance Rate for Microscopy by Organ System
Difference in Major
Discordance Rate
Major Discordance Rate for WSI Higher
than Major Discordance Rate for
Microscopy (Difference, in %)
Major Discordance Rate for WSI Lower
than Major Discordance Rate for
Microscopy (Difference, in %)
Major Discordance Rate for WSI
Identical to Microscopy
(Difference, in %)
< 1% Stomach (0.3) Breast (0.2) Peritoneal (0)
Skin (0.3) Respiratory (0.5) Gallbladder (0)
Brain (0.4) Lymph nodes (0.7) Appendix (0)
Colorectal (0.7) Soft tissue (0)
GE junction (0.7)
Prostate (0.8)
≥ 1% Gynecologic (1.2) Liver/bile duct (1)
Bladder (1.3) Salivary gland (1)
Kidney neoplastic (1.5) Peri(anal) (1)
Endocrine (1.8)
Major discordance rate for WSI—rate of major discordance between WSI and reference standard.
Major discordance rate for microscopy—rate of major discordance between microscopy and reference standard.
GE indicates gastroesophageal.
FIGURE 2. Difference in major discordance rates between WSI (WSI vs. reference standard) and microscopy (microscopy vs.
reference standard) for each of 20 organ systems included in the study. The y-axis is the difference (in %) between the major
discordance rate for WSI and the major discordance rate for microscopy. The x-axis lists the organ systems. For any given organ
system, a WSI minus microscopy difference >0 indicates that the overall major discordance rate for that organ system was greater
for WSI than for microscopy. A negative percentage indicates that the major discordance rate for that organ system was greater for
microscopy than for WSI. BD indicates bile duct; GE, gastroesophageal.
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prespeciﬁed noninferiority threshold of 4%,32 WSI was
considered noninferior to microscopy, meeting the pri-
mary objective of the study.
Major Discordance Rates by Organ System:
Microscopy Versus Reference Standard and WSI
Versus Reference Standard
For each organ system, major discordance rates
between microscopy and the reference standard, and be-
tween WSI and the reference standard are listed in
Table 3. For cases from the peritoneum, gallbladder,
appendix and soft tissue, there were no major discordances
between either microscopy or WSI and the reference
standard. For stomach and lymph node cases, discordance
rates were very low (< 1%) with both modalities. For most
other organs systems/tissues, discordance rates between
both modalities and the reference standard ranged from
1% to 4.9%. Major discordance rates between microscopy
and the reference standard were highest (≥ 5%) for
pathology of the brain, gynecologic tract, liver/bile
ducts, urinary bladder, and prostate. These were very
similar to the levels of discordance between WSI and the
reference standard, with the exception of liver/bile duct
cases, where major discordance rates for WSI were lower
than microscopy. Of all organs/organ systems included in
the study, prostate showed the highest major discordance
rates, which were seen with microscopy (11.3%) as well as
WSI (12%).
Overall, in 157/7596 reads (2%), there was a major
discordance between WSI and the reference standard in
cases where microscopy was concordant with the reference
standard. In 127/7566 reads (1.6%), there was a major
discordance between microscopy and the reference
standard in cases where WSI was concordant with the
reference standard.
Differences between major discordance rates for micro-
scopy and major discordance rates for WSI by organ system
are shown in Table 4 and depicted in Figure 2. For 4 organ
systems, there was no difference between major discordance
rates for the 2 modalities (peritoneum, gallbladder, appendix,
soft tissue). WSI major discordances were slightly higher
(<1%) in stomach, skin, brain, colorectum, gastroesophageal
junction, and prostate. The major discordance rate for WSI
was ≥1% higher than the major discordance rate for
microscopy in endocrine, neoplastic kidney, gynecologic, and
urinary bladder pathology. These 4 organs/organ systems
were selected for detailed analysis (see below). WSI major
discordance rates were ≥1% lower than the major discordance
rate for microscopy in liver/bile duct, salivary gland, and
(peri)anal pathology. These organs/organ systems, where
microscopy performed worse than WSI, were not subjected
to additional analysis.
Endocrine Pathology: Detailed Analysis
This analysis was based on paired reads, that is one read
by microscopy and one read by WSI for the same case by the
same pathologist. Since each case was read twice by 4 path-
ologists, there were 4 paired reads per case. Of 400 paired reads
on 100 cases in endocrine pathology, there were 9 reads in
which WSI was judged to show a major discordance with the
reference standard while the corresponding microscopic read
was not (Table 5). Details of the diagnosis in these cases are
provided in Table 6. Most of these occurrences (7) involved
thyroid pathology. Six were caused by under-diagnosis and
one by over-diagnosis of papillary thyroid carcinoma using
WSI. There was only one occurrence each in adrenal
pathology and pancreatic pathology. There were no cases in
which 3 pathologists or all 4 pathologists made a major
discordant diagnosis compared with the reference standard by
WSI but a concordant (or minor discordant) diagnosis by
microscopy. There was only 1 case in which 2/4 readers made
a major discordant diagnosis by WSI but a concordant
diagnosis by microscopy (case 0849, Table 6). The remaining
occurrences were random errors in which a single pathologist
(1/4) made a major discordant diagnosis by WSI but a
concordant (or minor discordant) diagnosis by microscopy; in
each of these instances, the remaining 3 pathologists made the
same diagnosis by WSI and microscopy.
Neoplastic Kidney Pathology: Detailed Analysis
Of 200 paired reads from 50 cases in neoplastic
kidney pathology, only 4 featured a major discordance
TABLE 5. Analysis of Organ Systems in Which Difference Between Major Discordance Rate for WSI and Major Discordance Rate
for Microscopy was ≥1%
Type of
Specimen
WSI: No Major
Discordance* Microscopy:
no Major Discordance
(No. Reads)
WSI: Major Discordance
Microscopy: no
Major Discordance
(No. Reads)
Microscopy: Major
Discordance WSI: no
Major Discordance
(No. Reads)
WSI Major Discordance:
Microscopy:
Major Discordance
(No. Reads)
Total Reads
(Cases)†
Endocrine
pathology
372 9 2 17 400 (100)
Neoplastic kidney
pathology
194 4 1 1 200 (50)
Urinary bladder
pathology
352 20 15 9 396 (99)
Gynecologic
pathology
550 19 12 19 600 (150)
*Discordance refers to discordance with reference standard, that is, original sign-out diagnosis.
†Each case was read by 4 pathologists (reads= cases×4).
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between WSI and the reference standard when microscopy
was concordant (or minor discordant) with the reference
standard (Table 7). There were no cases in which 3/4 or
4/4 readers made a discordant diagnosis compared with
the reference standard by WSI but a concordant/minor
discordant diagnosis by microscopy. There was only 1 case
in which 2/4 readers made a discordant diagnosis by WSI
but a concordant diagnosis by microscopy (case 1095,
Table 7). The 2 other occurrences were random errors
involving only a single pathologist.
Urinary Bladder Pathology: Detailed Analysis
There were 396 paired reads from 99 cases involving
pathology of the urinary bladder, of which 20 featured a
major discordance between WSI and the reference stand-
ard in the face of no major discrepancy between micro-
scopy and the reference standard (Table 8). These
involved interpretation of benign bladder biopsies in 5,
carcinomas in biopsies or transurethral resections in
3, noninvasive carcinomas in biopsies or transurethral
resections in 4, and carcinoma in a resected specimen
in 1. There were no consistent problem areas where
WSI caused diagnostic difﬁculties for all 4 readers
(or even 3/4 readers). There was only 1 case in which the
WSI diagnosis of 2 (of 4) readers was judged as a
major discordance when the corresponding microscopic
diagnosis was concordant or minor discordant (case 0276,
Table 8).
Gynecologic Pathology: Detailed Analysis
Of 600 paired reads from 150 cases in gynecologic
pathology, 19 paired reads involved a major discordance
between WSI and the reference standard when microscopy
was concordant or showed only a minor discordance
(Table 9). Most involved endometrial biopsies (8),
malignant diagnoses in the ovary (6), and cone biopsies
or loop electrosurgical excision procedure excisions of the
cervix (4). There were 3 cases in which 3 (of 4) pathologists
made a major discordant diagnosis compared with the
reference standard by WSI but a concordant or minor
discordant diagnosis by microscopy (Table 9, cases 0062,
0361, 0418). In case 0062, which featured an ovarian
tumor, 3 pathologists diagnosed carcinoma by microscopy
while making a benign or less aggressive diagnosis on
WSI. In case 0361 (endometrial biopsy), 3 pathologists
made a more aggressive diagnosis on WSI and a benign
diagnosis by microscopy. In case 0418, grading of
dysplasia was more aggressive on microscopy than on
WSI. As in the other organ systems where a detailed case-
by-case analysis was performed, there were no consistent
problem areas.
Overall, in the entire study set (1992 cases), there
were only 3 cases (all in gynecologic pathology, discussed
in the prior paragraph) where 3 of 4 pathologists made a
major discordant diagnosis by WSI while making a con-
cordant (or minor discordant) diagnosis by microscopy.
There was not a single case in the study in which all 4
pathologists made a major discordant diagnosis by WSI
TABLE 6. Endocrine Pathology: Paired Reads in Which WSI Yielded a Major Discordance but Microscopy Showed no Major
Discordance
Paired Reads of Same Case by Same Reader
Case
Number Reader* Reference Standard†
Diagnosis by WSI
(Major Discordance)
Diagnosis by Microscopy
(no Major Discordance)‡
0849 E Papillary thyroid carcinoma Nodular hyperplasia with a dominant
nodule
Papillary thyroid carcinoma
0849 H Papillary thyroid carcinoma Hyperplastic nodule Papillary carcinoma of thyroid, follicular
variant. Area of carcinoma surrounding
peripheral rim of hyperplastic nodule
0856 H Papillary thyroid carcinoma, follicular
variant
Hyperplastic nodules with oncocytic
metaplasia
Follicular carcinoma, oncocytic type
(minor discordance)
0524 E Papillary thyroid carcinoma, follicular
variant
Multinodular hyperplasia Papillary thyroid carcinoma
0521 E Papillary thyroid carcinoma Nodular hyperplasia Papillary thyroid carcinoma
0514 E Papillary thyroid carcinoma, classic type Nodular hyperplasia and changes
consistent with Graves disease
Follicular adenoma, would show to head
and neck pathologist to exclude
cribriform-morular variant of papillary
thyroid carcinoma (minor discordance)
0512 H Dominant hyperplastic nodule in a
background of diffuse follicular hyperplasia
with nodular changes consistent with
history of Graves’ disease. Chronic
lymphocytic thyroiditis.
Papillary thyroid carcinoma, follicular
variant
Hyperplastic thyroid nodule in a
background of chronic thyroiditis
0663 F Pheochromocytoma Adrenocortical adenoma Pheochromocytoma
0973 E Well-differentiated neuroendocrine tumor
of the pancreas, intermediate grade
Malignant diagnosis (yes), low grade Malignant diagnosis (yes), intermediate
grade
*The 4 reading pathologists at this site were designated E, F, G, and H.
†Original sign-out diagnosis.
‡Concordance or minor discordance compared with reference standard.
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while making a concordant (or minor discordant) diag-
nosis by microscopy.
DISCUSSION
The major question that validation studies of WSI
seek to answer is whether a pathologist will make the same
diagnosis on the same case using WSI as they would by
microscopy. For this purpose, a WSI diagnosis that is
“correct” is as satisfactory as a WSI diagnosis that is
“incorrect,” as long as the same diagnosis is made by
microscopy. Reﬂecting this principle, the 2013 CAP
guidelines state that “validation studies should establish
diagnostic concordance between digital and glass slides for
the same observer.”1 In keeping with these guidelines, our
study was designed primarily to measure variability be-
tween the same pathologist(s) for the same case using 2
different modalities. To the best of our knowledge, this is
the largest validation study performed in the United States
comparing WSI and microscopy for primary diagnosis in
surgical pathology. It is also the largest series worldwide in
terms of number of reads, and the second-largest series
worldwide in terms of cases.
In this study, several measures aimed at accurately
assessing intraobserver variability and mitigating the risk of
bias, including selection bias and recall bias.43 These mea-
sures included selection of consecutive cases, inclusion of a
validation pathologist to validate cases selected by the en-
rollment pathologist, randomization of reading order, divi-
sion of cases evenly into batches, randomization of cases
between reads, alternation of reading modalities by batch (ie,
a batch of microscopy cases was followed by a batch of WSI
cases on a different day), blinding of reading pathologists to
the reference standard diagnosis, and adjudication of con-
cordance by pathologists different from reading pathologists.
Many of these measures were either not considered in prior
studies or were not speciﬁed in published protocols. Table 10
lists the largest studies that have compared microscopy and
WSI for primary diagnosis in surgical pathology using cases
from a variety of organ systems, with adequate reporting of
major discrepancy rates.31,32,39 A major difference between
these studies and the current study is in the number of times
a study case was interpreted (read) speciﬁcally for the study
after the original sign-out. In 2 prior studies, each reading
pathologist interpreted each case only once during the study
(either by WSI or microscopy in Bauer et al32; by WSI only
in Snead et al31), which was compared with the original sign-
out diagnosis. In contrast, in the current study, each reading
pathologist interpreted each case twice during the study after
the original sign-out diagnosis. Hence, although the study by
Snead and colleagues included a larger number of cases
(3017 vs. 1992), the total number of reads performed during
their study (excluding the original sign-out diagnosis) was
lower (3017 vs. 15925). The study by Snead and colleagues
was most similar to the current study in terms of scope and
size, but the design of the 2 studies differed in the stringency
of measures taken to reduce bias. For example, adjudication
pathologists were different from the reading pathologists in
the current study and were selected from institutions different
from the reading pathologists, whereas reading pathologists
(participating pathologists) were included in the adjudication
panel (steering group) by Snead and colleagues. In both
studies, however, the difference in major discrepancy rates
for WSI and microscopy was reassuringly low (0.7% vs.
0.4%), supporting the contention that these methodologies
are essentially equivalent for rendering a primary diagnosis
in surgical pathology.
We were also able to report rates of interobserver
variability (rate of major discordance between WSI and
reference standard, or between microscopy and reference
standard). In surgical pathology, interobserver variability
is greatest in diagnostically challenging cases, and mainly
serves to highlight known problem areas where agreement
between observers is suboptimal, even among experts.46–48
These problems are compounded when general surgical
pathologists interpret cases that are difﬁcult even for
subspecialists, and when subspecialists interpret cases
that they do not sign out in their highly subspecialized
TABLE 7. Neoplastic Kidney Pathology: Paired Reads in Which WSI Yielded a Major Discordance but Microscopy Showed no Major
Discordance
Paired Reads of Same Case by Same Reader
Case
Number Reader* Reference Standard†
Diagnosis by WSI
(Major Discordance)
Diagnosis by Microscopy
(no Major Discordance)‡
1090 H Renal cell carcinoma, papillary type Metanephric adenoma. Would
show to expert
Papillary carcinoma. Would do
immunohistochemistry and show to expert
1095 F Papillary urothelial carcinoma, high
grade, with minute focus of early
superﬁcial invasion
High-grade papillary urothelial
carcinoma, noninvasive
High-grade papillary urothelial carcinoma,
noninvasive
1095 H Papillary urothelial carcinoma, high
grade, with minute focus of early
superﬁcial invasion
Urothelial carcinoma, low grade Papillary urothelial carcinoma, high grade
(minor discordance)
1102 H Cystic nephroma Multilocular cystic renal cell
carcinoma
Multilocular cystic renal cell carcinoma
(minor discordance)
*The 4 reading pathologists at this site were designated E, F, G, and H.
†Original sign-out diagnosis.
‡Concordance or minor discordance compared with reference standard.
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practices, as for some pathologists in this study. It is im-
portant to emphasize that reading pathologists in this
study were not permitted to use standard procedures that
would be available in “real-life” settings (and were possi-
bly available to the pathologist who originally signed out
the case, creating the reference standard diagnostic
benchmark), such as obtaining recuts or deeper levels,
comparing the case with prior specimens, ordering addi-
tional special stains, showing difﬁcult cases to colleagues
or obtaining extradepartmental consultation.
Given the effort expended in recent years to validate
WSI, its many potential beneﬁts are worth reemphasizing.43
WSI is already being used clinically in some centers for
providing consultations on difﬁcult cases to pathologists at
remote locations, providing frozen section interpretations at
distant sites, conducting slide conferences and tumor boards
with participants at off-site hospitals, performing proﬁciency
testing/quality assurance, decreasing problems associated with
retrieval of glass slides from physical storage sites for
comparison to current cases, eliminating problems with loss
of staining quality over time or loose cover slips, and using
scanned images for semiquantitative image analysis (eg,
HER2/neu, estrogen receptors, Ki-67). In the realm of edu-
cation, the ability of WSI to be “in many places at once”
obviates the need to physically transport glass slides, allows
for greater ﬂexibility in interacting locally with medical
students, residents, fellows, and faculty, and facilitates edu-
cational uses such as multicenter conferences, teaching con-
ferences at remote sites, and global pathology education.49–52
Virtual atlases containing hundreds of educational digital
images can be viewed or annotated any time and from any-
where. Links to WSI can be provided within journal articles,
TABLE 8. Urinary Bladder Pathology: Paired Reads in Which WSI Yielded a Major Discordance but Microscopy Showed no Major
Discordance
Paired Reads of Same Case by Same Reader
Case
Number Reader* Reference Standard† Diagnosis by WSI (Major Discordance)
Diagnosis by Microscopy
(no Major Discordance)‡
0202 A No pathologic abnormality Focal ﬂat high-grade urothelial carcinoma
in situ
Mild chronic cystitis with benign
reparative epithelial atypia
0208 A Papillary urothelial carcinoma, high
grade, noninvasive
Papillary high-grade urothelial carcinoma
invading at least into lamina propria
High-grade papillary urothelial carcinoma
in situ
0210 D High-grade papillary urothelial
carcinoma. There is focal invasion of
lamina propria
Noninvasive papillary urothelial
carcinoma, low-grade
Papillary urothelial carcinoma, high-
grade, without invasion (minor
discordance)
0211 D Papillary urothelial carcinoma, low-grade,
noninvasive
Invasive papillary urothelial carcinoma,
low-grade
Noninvasive papillary urothelial
carcinoma, low-grade
0221 A Bladder mucosa with chronic
inﬂammation and ﬁbrosis
Flat high-grade urothelial dysplasia Chronic cystitis with urothelial
hyperplasia
0227 A Suspicious for keratinizing squamous cell
carcinoma
Fibrosis; no evidence of malignancy High-grade urothelial carcinoma (minor
discordance)
0227 D Suspicious for keratinizing squamous cell
carcinoma
Minute fragment with mildly atypical
squamous epithelium; favor squamous
metaplasia
Minute fragment of tissue highly
suspicious for invasive squamous cell
carcinoma
0229 A High-grade myoinvasive urothelial
carcinoma
No histopathologic abnormality; no
evidence of malignancy
High-grade urothelial carcinoma invading
through bladder wall into perivesical soft
tissue
0231 A Acute and chronic cystitis with focal
mucosal ulceration
Myoinvasive high-grade urothelial
carcinoma
Mucosal ulceration and chronic cystitis
with benign reparative epithelial atypia
0243 A Mucosal ulceration with marked acute
and chronic inﬂammation extending
into muscularis propria
Myoinvasive high-grade urothelial
carcinoma
Erosive cystitis with granulomatous features
and benign reparative epithelial atypia
0245 D Urothelial carcinoma in situ Marked chronic cystitis Carcinoma in situ
0246 A Noninvasive high-grade urothelial
carcinoma
Papillary high-grade urothelial carcinoma
with invasion into lamina propria
Papillary high-grade urothelial carcinoma
in situ
0250 A Chronic cystitis with focal mucosa erosion Flat high-grade urothelial carcinoma
in situ
Erosive chronic cystitis with benign
reparative epithelial atypia
0265 A Noninvasive high-grade papillary
urothelial carcinoma
High-grade urothelial carcinoma with
invasion of lamina propria
Flat high-grade urothelial carcinoma
in situ
0276 B Focal high-grade urothelial dysplasia No pathologic abnormality No pathologic abnormality (minor
discordance)
0276 D Focal high-grade urothelial dysplasia No pathologic abnormality Atypical urothelium (minor discordance)
0280 B Flat high-grade urothelial carcinoma in situ Chronic inﬂammation Urothelial carcinoma in situ
0281 B Urothelial carcinoma in situ Reactive changes and chronic
inﬂammation
Urothelial carcinoma in situ
0501 B Urothelial carcinoma in situ Cystitis Chronic cystitis (minor discordant)
0507 B Urothelial carcinoma in situ Chronic inﬂammation Urothelial carcinoma in situ
*The 4 reading pathologists at this site were designated A, B, C, and D.
†Original sign-out diagnosis.
‡Concordance or minor discordance compared with reference standard.
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greatly increasing the educational value of the images
provided.52,53 The use of WSI also eliminates the need for
providing glass slides and recuts to students for educational
purposes and ensures that every student views the same image.
The reader is referred to reviews that address these issues in
greater detail.50,54 Digital pathology also has the potential to
underpin more advanced approaches to image analysis of
tissues to provide quantitative data at the point of scanning
that can support case selection, prioritization and diagnostic
evaluation of tissues to support tumor grading, biomarker
measurement, patient stratiﬁcation, immuno-oncology and
precision medicine.
The wide variety of cases included in this series allowed
us to perform a detailed analysis of major discordance rates by
organ system in order to determine if there were speciﬁc organ
systems, specimen types, or diagnostic categories where WSI
was consistently inferior to microscopy. Although we did
identify a few organ systems where the major discordance rate
for WSI (vs. reference standard) was slightly higher than the
major discordance rate for microscopy (vs. reference standard),
TABLE 9. Gynecologic Pathology: Paired Reads in Which WSI Yielded a Major Discordance but Microscopy Showed no Major
Discordance
Paired Reads of Same Case by Same Reader
Read Number/
Case Number Reader* Reference Standard†
Diagnosis by WSI
(Major Discordance)
Diagnosis by Microscopy
(No Major Discordance)‡
0048 A Borderline mucinous tumor Cystic corpus albicans Borderline mucinous tumor
0049 B Metastatic breast carcinoma Granulosa tumor Metastatic carcinoma consistent with
breast primary
0052 A High-grade serous papillary carcinoma
with undifferentiated features
Acute inﬂammation and necrotic
debris; no evidence of malignancy
Malignant mixed Müllerian tumor
(sarcomatoid carcinoma)
0062 A Endometrioid adenocarcinoma, grade 1 Multilocular serous cystadenomas
(bilateral) and borderline
endometrioid tumor (unilateral)
Mixed clear-cell adenocarcinoma/
endometrioid adenocarcinoma arising
from multicystic serous
cystadenoﬁbroma
0062 C Endometrioid adenocarcinoma, grade 1 Serous cystadenoma and borderline
serous (vs. endometrioid) tumor
Right—serous cystadenoﬁbroma; left—
serous carcinoma arising in
cystadenoﬁbroma (minor discordance)
0062 D Endometrioid adenocarcinoma, grade 1 Serous cystadenoma Right—serous cystadenoﬁbroma; left—
villoglandular carcinoma, favor
endometrioid (minor discordance)
0342 A Sparse superﬁcial strips and fragments of
endometrial tissue
CIN3 with benign endometrial
mucosa
Benign lower uterine segment mucosa
0346 A Endometrial polyp. Admixture of late
secretory and menstrual pattern
endometrium
Complex atypical endometrial
hyperplasia
Endometrial polyp and benign interval-
phase endometrial mucosa with
breakdown
0349 A Sparse superﬁcial strips of atrophic
endometrial epithelium
CIN3 and changes suggestive of
endocervical adenocarcinoma
in situ
Benign endocervical mucosa
0361 A Endometrial polyp with ﬂorid secretory
glands in a background of weakly
proliferative stromal breakdown
Complex atypical endometrial
hyperplasia in endometrial polyp
Benign secretory endometrial mucosa
0361 B Endometrial polyp with ﬂorid secretory
glands in a background of weakly
proliferative stromal breakdown
Endometrioid adenocarcinoma,
FIGO grade 1
Benign endometrium
0361 D Endometrial polyp with ﬂorid secretory
glands in a background of weakly
proliferative stromal breakdown
Atypical endometrial hyperplasia
fragments of endometrial polyp
Benign endometrial polyp
0370 A Secretory pattern endometrium Complex atypical endometrial
hyperplasia
Simple endometrial hyperplasia without
atypia
0384 A Proliferative pattern endometrium with
stromal breakdown
Endometrial adenocarcinoma, FIGO
grade 1
Focal simple endometrial hyperplasia
without atypia
0411 B CIN1 CIN2 CIN1
0418 A CIN2 Endocervical glandular hyperplasia Atypical endocervical glandular
proliferation (minor discordance)
0418 B CIN2 No pathologic abnormality CIN3
0418 C CIN2 Free-ﬂoating fragments of unoriented
dysplastic squamous epithelium,
favor LGSIL
CIN2
0424 D Focal acute cervicitis Focal high-grade squamous
intraepithelial lesion (moderate
dysplasia)
Squamous metaplasia
*The 4 reading pathologists at this site were designated A, B, C, and D.
†Original sign-out diagnosis.
‡Concordance or minor discordance compared with reference standard.
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a case-by-case analysis revealed no consistent vulnerabilities for
WSI when compared with microscopy. As 4 pathologists in-
terpreted each case by both modalities after the original sign-
out diagnosis, one would expect that if there were a consistent
technical problem that precluded an accurate diagnosis with
WSI, it would manifest as major discordances between WSI
and the reference standard for a given case but concordant
diagnoses between microscopy and the reference standard on
the same case. Further, one would expect this to occur with all
4 pathologists who viewed the case. For example, if identi-
ﬁcation of nuclear features of papillary thyroid carcinoma was
a consistent Achilles’ heel of WSI, one would expect that all 4
pathologists would misinterpret cases of papillary thyroid
carcinoma by WSI while making the correct diagnosis by
microscopy. Instead, our analysis showed that even in the most
problematic areas (eg, thyroid pathology), there was not even a
single case where all 4 pathologists consistently erred when
using WSI while making the correct diagnosis by microscopy.
These ﬁndings lend additional support to the contention that
cases where pathologists make an incorrect diagnosis by WSI
and a correct diagnosis by microscopy represent random error
by individual pathologists rather than a systematic or technical
problem attributable to the use of WSI. It is important to note
that although this manuscript focuses heavily on potential
vulnerabilities of WSI, there were also areas where microscopy
performed worse than WSI (Table 4). The choice to not
subject these areas to the same degree of scrutiny as WSI was
made since potential areas of vulnerability of WSI are of
greater concern to pathologists.
The strengths of this study include the multicenter,
blinded, randomized design, the inclusion of a wash-out
period, representation of both academic pathologists as well
as pathologists based in commercial laboratories, reading of
cases by pathologists who were not experts in the organ
systems they were assigned to interpret, and the inclusion of
margins and lymph nodes in many cases with resected tu-
mors, closely simulating real-life settings. The ability to recall
cases (memory bias)—a major concern in any intraobserver
variability study—was minimized by using a large number of
cases, consecutive cases with many “routine” diagnoses, a
wash-out period, and randomizing the reading order.
In summary, this study demonstrates that WSI is
noninferior to microscopy for the purpose of making a
primary diagnosis in surgical pathology. This conclusion
applies across a wide range of organ systems, sampling
methods, specimen types, stains, and practice settings. Our
ﬁndings have the potential to signiﬁcantly alter the
workﬂow of surgical pathologists in coming years and
pave the way for a purely digital workﬂow analogous to
the process currently used by radiologists.
TABLE 10. Comparison of Current Study to Selected Prior Studies Comparing WSI and Microscopy for Primary Diagnosis
in Surgical Pathology
Study Campbell Bauer Snead Current Study
Year of publication 2012 2013 2016 2017
No. cases 212 (312 parts) 607 (1025 parts) 3017 1992
No. pathologists interpreting slides in the study 2 2 17 16
No. reads* 424 1025 3017 15925
Training period on WSI was part of study Not speciﬁed Yes Yes Yes
Device used for WSI iScan Aperio ScanScopeXT Omnyx VL4 Philips IntelliSite
Pathology Solution
Magniﬁcation at which scanning was
performed
20× 20× 40× (60× for renal
biopsies and some others)
40×
Wash-out period Not speciﬁed 1 y 3 wk 4 wk
Consecutive cases selected Yes Yes Yes No
Separate pathologist validated enrolled cases Not speciﬁed No No Yes
Cases randomized for reading order Not speciﬁed Not speciﬁed Not speciﬁed Yes
Batches alternated for reading modality Not speciﬁed Not speciﬁed Not speciﬁed Yes
Reading pathologists blinded to original sign-
out diagnosis
Yes Yes Yes Yes
Reading pathologists evaluated each case by
both WSI and microscopy during study
No No No Yes
Adjudication only by pathologists different
from reading pathologists
Yes Yes No Yes
Adjudication only by pathologists from
different institution than reading
pathologists
No No No Yes
Adjudication pathologists blinded† No Not speciﬁed Not Speciﬁed Yes
Statistician blinded to modality and
randomization scheme
Not speciﬁed Not speciﬁed Not speciﬁed Yes
Areas of concern for WSI None Over-calling of eosinophilic
esophagitis, missed intramucosal
adenocarcinoma, one case with higher
Gleason score, one active colitis called
normal
Over-calling of dysplasia,
under-detection of
organisms
Endocrine
pathology,
neoplastic kidney
pathology
*Number of diagnoses rendered speciﬁcally for the study (excluding original sign-out microscopic diagnosis performed for patient care).
†Adjudication pathologists were blinded to reading modality, clinical diagnosis, reading pathologist, and “correct diagnosis.”
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